FDA inspection

Solaris Pharma Corporation: FDA inspection ending Apr 21, 2026

FDA inspection 1317052 · Somerset, NJ

Key facts

Inspection ID 1317052
Firm Solaris Pharma Corporation
FEI number 3012158090
Address 49 Napoleon Ct
City Somerset
State NJ
ZIP 08873-1392
Fiscal year 2026
Inspection end date Apr 21, 2026
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections